chr2-227307878-T-C

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 1P and 9B. PP3BP4_StrongBS1_SupportingBS2

The NM_000091.5(COL4A3):​c.4421T>C​(p.Leu1474Pro) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0044 in 1,614,166 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0024 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0046 ( 23 hom. )

Consequence

COL4A3
NM_000091.5 missense

Scores

13
4
1

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7U:14B:7

Conservation

PhyloP100: 7.67

Publications

30 publications found
Variant links:
Genes affected
COL4A3 (HGNC:2204): (collagen type IV alpha 3 chain) Type IV collagen, the major structural component of basement membranes, is a multimeric protein composed of 3 alpha subunits. These subunits are encoded by 6 different genes, alpha 1 through alpha 6, each of which can form a triple helix structure with 2 other subunits to form type IV collagen. This gene encodes alpha 3. In the Goodpasture syndrome, autoantibodies bind to the collagen molecules in the basement membranes of alveoli and glomeruli. The epitopes that elicit these autoantibodies are localized largely to the non-collagenous C-terminal domain of the protein. A specific kinase phosphorylates amino acids in this same C-terminal region and the expression of this kinase is upregulated during pathogenesis. This gene is also linked to an autosomal recessive form of Alport syndrome. The mutations contributing to this syndrome are also located within the exons that encode this C-terminal region. Like the other members of the type IV collagen gene family, this gene is organized in a head-to-head conformation with another type IV collagen gene so that each gene pair shares a common promoter. [provided by RefSeq, Jun 2010]
MFF-DT (HGNC:41067): (MFF divergent transcript)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

PP3
Multiple lines of computational evidence support a deleterious effect 10: AlphaMissense, BayesDel_addAF, BayesDel_noAF, Eigen, M_CAP, MutationAssessor, phyloP100way_vertebrate, PROVEAN, REVEL, REVEL [when max_spliceai, FATHMM_MKL, MetaRNN, MutationTaster was below the threshold]
BP4
Computational evidence support a benign effect (MetaRNN=0.038383782).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00244 (372/152304) while in subpopulation NFE AF = 0.00426 (290/68014). AF 95% confidence interval is 0.00386. There are 0 homozygotes in GnomAd4. There are 160 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High Homozygotes in GnomAdExome4 at 23 AD,AR,SD gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000091.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
NM_000091.5
MANE Select
c.4421T>Cp.Leu1474Pro
missense
Exon 48 of 52NP_000082.2Q01955-1
MFF-DT
NR_102371.1
n.48-2223A>G
intron
N/A

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
COL4A3
ENST00000396578.8
TSL:1 MANE Select
c.4421T>Cp.Leu1474Pro
missense
Exon 48 of 52ENSP00000379823.3Q01955-1
COL4A3
ENST00000469504.2
TSL:1
n.392T>C
non_coding_transcript_exon
Exon 3 of 6ENSP00000493493.1A0A2R8Y2F0
MFF-DT
ENST00000439598.6
TSL:1
n.48-2223A>G
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.00244
AC:
372
AN:
152186
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000989
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000282
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00426
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00270
AC:
673
AN:
249412
AF XY:
0.00259
show subpopulations
Gnomad AFR exome
AF:
0.000775
Gnomad AMR exome
AF:
0.00217
Gnomad ASJ exome
AF:
0.0000993
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000325
Gnomad NFE exome
AF:
0.00502
Gnomad OTH exome
AF:
0.00165
GnomAD4 exome
AF:
0.00460
AC:
6724
AN:
1461862
Hom.:
23
Cov.:
32
AF XY:
0.00444
AC XY:
3231
AN XY:
727232
show subpopulations
African (AFR)
AF:
0.000717
AC:
24
AN:
33480
American (AMR)
AF:
0.00190
AC:
85
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0000383
AC:
1
AN:
26136
East Asian (EAS)
AF:
0.0000252
AC:
1
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000337
AC:
18
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5764
European-Non Finnish (NFE)
AF:
0.00577
AC:
6415
AN:
1111988
Other (OTH)
AF:
0.00295
AC:
178
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
347
695
1042
1390
1737
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00244
AC:
372
AN:
152304
Hom.:
0
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000986
AC:
41
AN:
41568
American (AMR)
AF:
0.00209
AC:
32
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5188
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.000282
AC:
3
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00426
AC:
290
AN:
68014
Other (OTH)
AF:
0.00284
AC:
6
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
17
34
52
69
86
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00375
Hom.:
4
Bravo
AF:
0.00267
TwinsUK
AF:
0.00728
AC:
27
ALSPAC
AF:
0.00571
AC:
22
ESP6500AA
AF:
0.000793
AC:
3
ESP6500EA
AF:
0.00414
AC:
34
ExAC
AF:
0.00275
AC:
332
EpiCase
AF:
0.00513
EpiControl
AF:
0.00439

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
1
5
4
not provided (10)
2
3
-
Autosomal recessive Alport syndrome (5)
-
3
1
Alport syndrome (4)
1
2
-
Autosomal dominant Alport syndrome (3)
1
1
-
COL4A3-related disorder (2)
-
-
2
not specified (2)
1
-
-
Benign familial hematuria (1)
1
-
-
Hearing impairment (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.94
BayesDel_addAF
Pathogenic
0.22
D
BayesDel_noAF
Pathogenic
0.55
CADD
Uncertain
24
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.64
D
Eigen
Pathogenic
0.88
Eigen_PC
Pathogenic
0.78
FATHMM_MKL
Pathogenic
0.98
D
LIST_S2
Uncertain
0.91
D
M_CAP
Pathogenic
0.72
D
MetaRNN
Benign
0.038
T
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Pathogenic
3.7
H
PhyloP100
7.7
PrimateAI
Uncertain
0.67
T
PROVEAN
Pathogenic
-6.0
D
REVEL
Pathogenic
0.79
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.98
MVP
0.97
MPC
0.30
ClinPred
0.088
T
GERP RS
5.9
PromoterAI
0.0038
Neutral
Varity_R
0.96
gMVP
0.91
Mutation Taster
=4/96
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs200302125; hg19: chr2-228172594; COSMIC: COSV106114645; COSMIC: COSV106114645; API